On average, CES appears to have provided a small but statistically significant improvement in pain intensity and pain interference with few troublesome side effects. During the 21-day trial, there was a significant group × time interaction for only one outcome variable the active group showed larger pre- to post-treatment decreases in pain interference than the sham group did (F = 8.50, P < 0.01, d = 0.59).
The active group reported a significantly greater average decrease in pain during daily treatments than the sham group (Kruskal-Wallis chi-square = 4.70, P < 0.05). Six-month open-label phase to assess 'as-needed' CES use.Ĭhange in pre- to post-session pain ratings as well as change in pain intensity, pain interference, pain quality, pain beliefs and coping strategies, general physical and mental health status, depressive symptomatology, perceived stress, and anxiety pre- to post-treatment. Study design: Multi-site, double-blind, sham-controlled study.Īdults with SCI and chronic neuropathic pain at or below the level of injury were randomized to receive active or sham CES.Īpplication of active CES or sham CES 1 hour daily for 21 days. It involves the application of a small amount of current through the head via ear clip electrodes.Įxplore the effectiveness of CES for neuropathic pain in persons with SCI and chronic pain. Cranial electrotherapy stimulation (CES) has been effective in managing some types of pain. Unfortunately, SCI-related neuropathic pain has proven to be largely refractory to analgesic medications and other available treatments. Chronic pain is a significant problem for many individuals following spinal cord injury (SCI).
0 kommentar(er)
